Thank you for your message!
We will get in touch with you soon.
Digital Therapeutics
Digital therapeutics provide a viable solution to bridging the ever-growing treatment-gap for many indications, relieving strain on patients, physicians and psychotherapists.
Our digital therapeutics are CE-marked medical devices with clinically validated effectiveness.
- Safe and easy-to-access for patients
- Highly beneficial to existing diagnoses and therapies
- Proven effectiveness in numerous studies
- CE marked and approved as medical products
ABOUT THE PRODUCTS
A short view on our product philosophy
Clinically Validated Effectiveness
Our mission is to develop digital therapeutics that offer physicians, therapists, payers and patients the same effect sizes, similar safety profiles and equal levels of convenience as found in well-developed, pharmaceutical solutions.
One of our most researched products is deprexis®, the online program for the treatment of depression. deprexis® has been shown to effectively reduce symptoms of depression in 13 randomized controlled trials (RCTs) as well as in real-life, clinical settings with effect sizes similar to those of antidepressants.
Technology & Functionality
Our expert system technology platform broca® forms the backbone of more than 70 products developed to date. broca® has set healthcare industry benchmarks for individualized web-based solutions. broca allows our products to simulate 1:1 coaching, training or therapy sessions, in which a virtual expert and a user interact to achieve a common goal. Similar to a chess computer, broca® facilitates rapid learning, thought process change and deep skill acquisition in a dynamic and individual flow. The platform engages users continuously in interactive exercises and guides them, step-by-step, towards specific goals and therapeutic targets.
Individual & Data Secure
The latest version of our broca® 4 platform has the flexibility to run our highly individualized products on nearly all web-compatible devices. Our broca® 4 platform enables us to produce even more targeted and custom-tailored interventions, all the while ensuring that the user remains in full control of their data.
All patient data is treated as strictly confidential as when talking to a doctor or therapist, and is neither sold nor passed on to third parties. Our applications comply with the EU General Data Protection Regulation (EU GDPR).
International Partners
GAIA has successfully implemented a large number of digital therapy projects with international partners, including payer organizations and pharmaceutical companies. Our long-term partners include Airbus, AOK, B. Braun, DAK, HanseMerkur, Ferring, Ethypharm, E. Lilly, J & J, Lundbeck, Merck, Merz, Orexo, Pfizer, Servier and Ethypharm.
